Lucintel's latest market report analyzed that animal parasiticide provides attractive opportunities in the veterinary clinics & hospitals, animal farms, and home care settings. The animal parasiticide market is expected to reach $15.5 billion by 2028 with a CAGR of 7%. In this market, ectoparasiticide is the largest segment by product type, whereas veterinary clinics & hospitalsis largest by end use industry.
Download Brochure of this report by clicking on https://www.lucintel.com/animal-parasiticide-market.aspx
Based on product type, the animal parasiticide market is segmented into ectoparasiticides, endoparasiticides, and endectocides. The ectoparasiticide segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to increasing pet ownership and escalating demand for companion animals in the developed countries.
Browse in-depth TOC on “Animal ParasiticideMarket”
100 – Figures/Tables
150 – Pages
The Animal Parasiticide Market is marked by the presence of several big and small players. Some of the prominent players offering animal parasiticide include Zoetis, Elanco Animal Health, Virbac, Merck, and BoehringerIngelheim.
Request Sample Report:
https://www.lucintel.com/animal-parasiticide-market.aspx
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.